Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. scores highest on Nitro (89) and lowest on Anchor (48). Its PosiPenta is 67.63 out of 100, better than most similar companies.
On the Penta Grid this week, Rigel Pharmaceuticals, Inc. is Grid #32 of 837 in the Healthcare sector in United States, and Grid #97 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Rigel Pharmaceuticals, Inc. | 67.63 | 72 | 53 | 89 | 76 | 48 |
| Verastem, Inc. | 38.26 | 4 | 42 | 83 | 9 | 53 |
| Cullinan Therapeutics, Inc. | 41.24 | 25 | 29 | 60 | 63 | 29 |
| Odyssey Therapeutics, Inc. | 44.57 | 29 | 32 | 51 | 57 | 53 |
| QuidelOrtho Corporation | 40.97 | 46 | 44 | 35 | 31 | 49 |
| Corvus Pharmaceuticals, Inc. | 40.68 | 18 | 34 | 37 | 69 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 2.72 |
| P/B ratio | 2.02 |
EEarnings
| Trailing EPS | ₹1598.79 |
| Forward EPS | ₹467.81 |
NNitro
| Price | 4354.05 |
| 52-week high | 4947.91 |
| 52-week low | 2363.14 |
| Fall from 52-week high | 12.0% |
TTorque
| Return on equity (ROE) | 126.90% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | 1.19 |
| Market cap | ₹8,133 Cr |
| Insider holding | 3.35% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Rigel Pharmaceuticals, Inc.'s PosiPenta score?
Rigel Pharmaceuticals, Inc.'s PosiPenta is 67.63 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Rigel Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Rigel Pharmaceuticals, Inc. is Grid #32 of 837 in the Healthcare sector in United States, and Grid #97 of 4,000 in United States.
Which PosiPenta pillar is strongest for Rigel Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Rigel Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 48 out of 100: around the middle of similar companies.
Has Rigel Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it fell 0.79 points, from 68.42 to 67.63.
PositoAI is for research and education only and is not investment advice.